Literature DB >> 22886024

Mass spectrometric characterization of amyloid-β species in the 7PA2 cell model of Alzheimer's disease.

Erik Portelius1, Maria Olsson, Gunnar Brinkmalm, Ulla Rüetschi, Niklas Mattsson, Ulf Andreasson, Johan Gobom, Ann Brinkmalm, Mikko Hölttä, Kaj Blennow, Henrik Zetterberg.   

Abstract

The Chinese hamster ovary cell line 7PA2, stably transfected with the 751 amino acid isoform of amyloid-β protein precursor (AβPP) containing the ValPhe mutation at residue 717, is one of the most used models to study the biochemistry and toxicity of secreted amyloid-β (Aβ) peptides, particularly Aβ oligomers, which are considered to be of relevance to the pathogenesis of Alzheimer's disease. Here, we present a detailed immunochemical and mass spectrometric characterization of primary structures of Aβ peptides secreted by 7PA2 cells. Immunoprecipitation and western blot of 7PA2 cell culture media revealed abundant anti-Aβ immunoreactive bands in the molecular weight range of 4-20 kDa. Mass spectrometric analysis showed that these bands contain several AβPP/Aβ peptides, starting at the N-terminal of the Aβ sequence and extending across the BACE1 cleavage site. Treatment of cells with a BACE1 inhibitor decreased the abundance of the Aβ monomer band by western blot and resulted in lower levels of Aβ1-40, Aβ1-42, and sAβPPβ as measured by ELISA. However, western blot bands thought to represent oligomers of Aβ increased in response to BACE1 inhibition. This increase was paralleled by the emergence of N-terminally truncated Aβ species (Aβ5-40 in particular) and Aβ species that spanned the β-secretase site in AβPP according to mass spectrometric analyses. The formation of these AβPP/Aβ peptides may have implications for the use of the 7PA2 cell line as a model for Aβ pathology. The enzyme(s) responsible for this particular BACE1-independent AβPP-processing remains to be identified.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22886024     DOI: 10.3233/JAD-2012-120994

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  22 in total

1.  New tricks from an old dog: Another synaptotoxic fragment from APP.

Authors:  Sheue-Houy Tyan; Edward H Koo
Journal:  Cell Res       Date:  2015-10-27       Impact factor: 25.617

2.  The aqueous phase of Alzheimer's disease brain contains assemblies built from ∼4 and ∼7 kDa Aβ species.

Authors:  Jessica M Mc Donald; Tiernan T O'Malley; Wen Liu; Alexandra J Mably; Gunnar Brinkmalm; Erik Portelius; William M Wittbold; Matthew P Frosch; Dominic M Walsh
Journal:  Alzheimers Dement       Date:  2015-04-04       Impact factor: 21.566

Review 3.  Inhibiting BACE1 to reverse synaptic dysfunctions in Alzheimer's disease.

Authors:  Riqiang Yan; Qingyuan Fan; John Zhou; Robert Vassar
Journal:  Neurosci Biobehav Rev       Date:  2016-04-01       Impact factor: 8.989

4.  Induction of Amyloid-β42 Production by Fipronil and Other Pyrazole Insecticides.

Authors:  Morgane Cam; Emilie Durieu; Marion Bodin; Antigoni Manousopoulou; Svenja Koslowski; Natalia Vasylieva; Bogdan Barnych; Bruce D Hammock; Bettina Bohl; Philipp Koch; Chiori Omori; Kazuo Yamamoto; Saori Hata; Toshiharu Suzuki; Frank Karg; Patrick Gizzi; Vesna Erakovic Haber; Vlatka Bencetic Mihaljevic; Branka Tavcar; Erik Portelius; Josef Pannee; Kaj Blennow; Henrik Zetterberg; Spiros D Garbis; Pierrick Auvray; Hermeto Gerber; Jeremy Fraering; Patrick C Fraering; Laurent Meijer
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 5.  Toxic oligomer species of amyloid-β in Alzheimer's disease, a timing issue.

Authors:  Sylvain E Lesne
Journal:  Swiss Med Wkly       Date:  2014-11-06       Impact factor: 2.193

6.  Human Brain-Derived Aβ Oligomers Bind to Synapses and Disrupt Synaptic Activity in a Manner That Requires APP.

Authors:  Zemin Wang; Rosemary J Jackson; Wei Hong; Walter M Taylor; Grant T Corbett; Arturo Moreno; Wen Liu; Shaomin Li; Matthew P Frosch; Inna Slutsky; Tracy L Young-Pearse; Tara L Spires-Jones; Dominic M Walsh
Journal:  J Neurosci       Date:  2017-11-03       Impact factor: 6.167

7.  N-Terminal Extensions Retard Aβ42 Fibril Formation but Allow Cross-Seeding and Coaggregation with Aβ42.

Authors:  Olga Szczepankiewicz; Björn Linse; Georg Meisl; Eva Thulin; Birgitta Frohm; Carlo Sala Frigerio; Michael T Colvin; Angela C Jacavone; Robert G Griffin; Tuomas Knowles; Dominic M Walsh; Sara Linse
Journal:  J Am Chem Soc       Date:  2015-11-17       Impact factor: 15.419

8.  η-Secretase processing of APP inhibits neuronal activity in the hippocampus.

Authors:  Michael Willem; Sabina Tahirovic; Marc Aurel Busche; Saak V Ovsepian; Magda Chafai; Scherazad Kootar; Daniel Hornburg; Lewis D B Evans; Steven Moore; Anna Daria; Heike Hampel; Veronika Müller; Camilla Giudici; Brigitte Nuscher; Andrea Wenninger-Weinzierl; Elisabeth Kremmer; Michael T Heneka; Dietmar R Thal; Vilmantas Giedraitis; Lars Lannfelt; Ulrike Müller; Frederick J Livesey; Felix Meissner; Jochen Herms; Arthur Konnerth; Hélène Marie; Christian Haass
Journal:  Nature       Date:  2015-08-31       Impact factor: 49.962

9.  Normal cognition in transgenic BRI2-Aβ mice.

Authors:  Jungsu Kim; Paramita Chakrabarty; Amanda Hanna; Amelia March; Dennis W Dickson; David R Borchelt; Todd Golde; Christopher Janus
Journal:  Mol Neurodegener       Date:  2013-05-12       Impact factor: 14.195

10.  Lessons from a Rare Familial Dementia: Amyloid and Beyond.

Authors:  Adam Cantlon; Carlo Sala Frigerio; Dominic M Walsh
Journal:  J Parkinsons Dis Alzheimers Dis       Date:  2015-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.